Severe imported malaria in adults;Paludisme grave d'importation de l'adulte

Medecine et Maladies Infectieuses

Volumn 36, Issue 10, 2006, Pages 492-498

  Petrognani, R ^a   Peytel, E ^a   Ponchel, C ^a   Carpentier, J P ^a   Saissy J M ^b  

^a LAVERAN MILITARY TEACHING HOSPITAL   (France)

^b SERVICE DE SANTÉ DES ARMÉES   (France)

Author keywords

Plasmodium faciparum; Quinine; Severe malaria; Severe sepsis

Indexed keywords

ANTIBIOTIC AGENT; ANTIMALARIAL AGENT; ARTEMETHER; ARTEMISININ DERIVATIVE; ARTESUNATE; BENZODIAZEPINE; CHLORIDE; CHLOROQUINE; CINCHONIDINE; CINCHONINE; CLINDAMYCIN; DIAZEPAM; DOXYCYCLINE; FORMIC ACID; HALOFANTRINE; MEFLOQUINE; QUINIDINE; QUINIMAX; QUININE; QUININE FORMATE;

ADJUVANT THERAPY; AFRICA SOUTH OF THE SAHARA; ANEMIA; ARTIFICIAL VENTILATION; ASSISTED VENTILATION; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; CONVULSION; DISEASE FREE SURVIVAL; DISEASE SEVERITY; DRUG EFFICACY; DRUG POTENTIATION; EMPORIATRICS; ENDEMIC DISEASE; ERYTHROCYTE ADHESIVENESS; FRANCE; GRAM NEGATIVE SEPSIS; HEMOSTASIS; HIGH RISK POPULATION; HOST PARASITE INTERACTION; HUMAN; HYPOGLYCEMIA; INFECTION PREVENTION; INFLAMMATION; INTENSIVE CARE UNIT; KIDNEY DISEASE; LACTIC ACIDOSIS; LEISURE; LIVER FAILURE; MALARIA; MENTAL HEALTH; METABOLIC ACIDOSIS; MULTIPLE ORGAN FAILURE; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN THERAPY; PALLIATIVE THERAPY; PARASITEMIA; PATHOPHYSIOLOGY; PLASMODIUM FALCIPARUM; PROGNOSIS; RENAL REPLACEMENT THERAPY; RESPIRATORY DISTRESS; RESPIRATORY FAILURE; ROSETTE FORMATION; SHORT SURVEY; TREATMENT CONTRAINDICATION;

EID: 33751402180     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2006.07.015     Document Type: Short Survey

References (56)

1. Bruneel F., Hocqueloux L., Alberti C., Wolff M., Chevret S., Bedos J.P., et al. The clinical spectrum of severe imported falciparum malaria in the intensive care unit: report of 188 cases in adults. Am. J. Respir. Crit. Care Med. 167 (2003) 684-689
2. Danis M., and Faliu B. Santé des voyageurs et recommandations sanitaires. BEH 24-25 (2005) 117-128
3. Saïssy J.M., Rouvin B., and Koulmann P. Le paludisme grave en réanimation en 2003. Med. Trop. 63 (2003) 258-266
4. Idro R., Jenkins N.E., and Newton C.R.J. Pathogenesis, clinical features, and neurological outcomes of cerebral malaria. Lancet Neurol. 4 (2005) 827-840
5. Kirchgatter K., and Del Portillo H.A. Clinical and molecular aspects of severe malaria. An. Acad. Bras. Cienc. 77 (2005) 455-475
6. Coltel N., Combes V., Nicholas H.H., and Grau G.E. Cerebral malaria. A neurovascular pathology with many riddles still to be solved. Curr. Neuovasc. Res. 1 (2004) 91-110
7. Baruch D.I., Gormely J.A., Ma C., Howard R.J., and Pasloske B.L. Plasmodium falciparum erythrocyte membrane protein 1 as a parasitized erythrocyte receptor for adherence to CD36, thrombospondin, and intracellular adhesion molecule 1. Proc. Natl. Acad. Sci. USA 93 (1996) 3497-3502
8. Su X.Z., Heatwole V.M., Wertheimer S.P., Guinet F., Herrfeldt J.A., Peterson D.S., et al. The large diverse gene family var encodes proteins involved in cytoadherence and antigenic variation of Plasmodium falciparum-infected erythrocytes. Cell 82 (1995) 89-100
9. Udomsangpetch R., Reinhard P.H., Schollaardt T., Elliott J.F., Kubes P., and Ho M. Promiscuity of clinical Plasmodium falciparum isolates for multiple adhesion molecules under flow conditions. J. Immunol. 158 (1997) 4358-4364
10. Ho M., and White N.J. Molecular mechanisms of cytoadherence in malaria. Am. J. Physiol. 276 (1999) 1231-1242
11. Newbold C., Craig A., Kyes S., Rowe A., Fernandez-Reyes D., and Fagan T. Cytoadherence, pathogenesis and the infected red cell surface in Plasmodium falciparum. Int. J. Parasitol. 29 (1999) 927-937
12. David P.H., Hommel M., Miller L.H., Udeinya I.J., and Oligino L.D. Parasite sequestration in Plasmodium falciparum malaria: spleen and antibody modulation of cytoadherence of infected erythrocytes. Proc. Natl. Acad. Sci. USA 80 (1983) 5075-5079
13. Bone R.C., Balk R.A., Cerra F.B., Dellinger R.P., Fein A.M., Knaus W.A., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101 (1992) 1644-1655
14. Grau G.E., Piguet P.F., Vassalli P., and Lambert P.H. Tumour necrosis factor and other cytokines in cerebral malaria: experimental and clinical data. Immunol. Rev. 112 (1989) 49-70
15. Grau G.E., Taylor T.E., Molyneux M.E., Wirima J.J., Vassalli P., Hommel M., et al. Tumour necrosis factor and disease severity in children with falciparum malaria. New Engl. J. Med. 320 (1989) 1586-1591
16. Kwiatowski D., Hill A.V.S., Sambon I., et al. TNF concentration in fatal cerebral, non fatal cerebral and uncomplicated Plasmodium falciparum malaria. Lancet 336 (1990) 1201-1204
17. Grau G.E., Pointaire P., Piguet P.F., Vesin C., Rosen H., Stamenkovic I., et al. Late administration of monoclonal antibody to leukocyte function-antigen 1 abrogates incipient murine cerebral malaria. Eur. J. Immunol. 24 (2002) 387-389
18. Orago A.S., and Facer C.A. Cytokine-induced inhibition of Plasmodium falciparum erythocytic growth in vitro. Clin. Exp. Immunol. 91 (1993) 287-294
19. Doolan D.L., and Hoffman S.L. IL-12 and NK cells are required for antigen-specific adaptive immunity against malaria initiated by CD8+ T cells in the Plasmodium yoelii model. J. Immunol. 163 (1999) 884-892
20. Ockenhouse C.F., and Shear H.L. Oxidative killing of the intraerythrocytic malaria parasite Plasmodium yoelii by activated macrophages. J. Immunol. 132 (1984) 424-431
21. Essner R., Rhoades K., McBride X.H., Morton D.L., and Economou J.S. IL-4 down-regulates IL-1 and TNF gene expression in human monocytes. J. Immunol. 142 (1989) 3857-3861
22. Danis M., Legros F., Thellier M., and Caumes E. Données actuelles sur le paludisme en France métropolitaine. Med. Trop. 62 (2002) 214-218
23. World Health Organization. Severe falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 94 suppl 1 (2000) 1-9O
24. Prise en charge et prévention du paludisme d'importation à Plasmodium faciparum. Med. Mal. Infect. 29 (1999) 375-379
25. Planche T., and Krishna S. The relevance of malaria pathophysiology to strategies of clinical management. Curr. Opin. Infect. Dis. 18 (2005) 369-375
26. Looareesuwan S., Wilairatana P., Krishna S., Kendall B., Vannaphan S., Viravan C., et al. Magnetic resonance imagining of the brain in patients with cerebral malaria. Clin. Infect. Dis. 21 (1995) 300-309
27. Taylor W.R.J., and White N.J. Malaria and the lung. Clin. Chest Med. 23 (2002) 457-468
28. Charoenpan P., Indraprasit S., Kiatboonsri S., Suvachittanont O., and Tanomsup S. Pulmonary edema in severe falciparum malaria. Hemodynamic study and clinicophysiologic correlation. Chest 97 (1990) 1190-1197
29. Devarbhavi H., Alvares J.F., and Kumar K.S. Severe falciparum malaria simulating fulminans hepatic failure. Mayo Clin. Proc. 80 (2005) 355-358
30. Saïssy J.M., Seck M., Rouvin B., Diatta B., Ndiaye M., and Angel G. Hemodynamic aspects and oxygenation variables in severe malaria of adults in Africa. Intensive Care Med. 26 (2000) 1449-1453
31. Clark I.A. Does endotoxin cause both the disease an parasite death in acute malaria and babesiosis?. Lancet 324 (1978) 75-77
32. Day N.P.J., Phu N.H., and Loc P.P. Malaria and acute renal failure. J. R. Coll. Physicians Lond. 31 (1997) 146-148
33. Barsoum R.S. Malaria acute renal failure. J. Am. Soc. Nephrol. 11 (2000) 2147-2154
34. Sinniah R., and Lye W.C. Acute renal failure from myoglobinuria secondary to myositis from severe falciparum malaria. Am. J. Nephrol. 20 (2000) 339-343
35. Phillips R.E., Looaresuwan S., Warrell D.A., Lee S.H., Karbwang J., Warrell M., et al. The importance of anaemia in cerebral and uncomplicated falciparum malaria: role of complications, dyserthropoiesis and iron sequestration. Q. J. Med. 58 (1986) 305-323
36. Mohanty D., Marwaha N., and Ghosh K. Vascular occlusion and disseminated intravascular coagulation in falciparum malaria. BMJ 290 (1985) 115-116
37. Van Genderen P.J.J., van der Meer I.M., Consten J., Petit P.L.C., van Gool T., and Overbosch D. Evaluation of plasma lactate as a parameter for disease severity on admission in travelers with Plasmodium falciparum malaria. J. Travel Med. 12 (2005) 261-264
38. Day N.P., Phu N.H., Mai N.T.H., Chau T.T.H., Loc P.P.L., Chuong L.V., et al. The pathophysiologic and prognostic signifiance of acidosis in severe adult malaria. Crit. Care Med. 28 (2000) 1833-1840
39. Lichtman A.R., Mohrcken S., Engelbrecht M., and Bilgalke M. Pathophysiology of severe forms of falciparum malaria. Crit. Care Med. 18 (1990) 666-668
40. White N.J., Warrell D.A., Chanthavanich P., Looareesuwan S., Warrell M.J., Krishna S., et al. Severe hypoglycemia and hyperinsulinemia in falciparum malaria. N. Engl. J. Med. 309 (1983) 61-66
41. Bruneel F., Gachot B., Wolff M., Regnier B., Danis M., Vachon F., and and the Corresponding Group. Resurgence of blackwater fever in long-term european expatriates in Africa : report of 21 cases and review. Clin. Infect. Dis. 32 (2001) 1133-1140
42. Vachon F., Fajac I., Gachot B., Coulaud J.P., and Charmot G. Halofantrine and acute intravascular haemolysis. Lancet 340 (1992) 909-910
43. White N.J. The treatement of malaria. N. Engl. J. Med. 335 (1996) 800-806
44. Pukrittayakamee S., Supanaranond W., Loooareesuwan S., Vanijanonta S., and White N.J. Quinine in severe falciparum malaria: evidence of declining efficacy in Thailand. Trans. R. Soc. Trop. Med. Hyg. 88 (1994) 324-327
45. White N.J., Looareesuwan S., Warrell M.J., Bunna G., and Harinasuta T. Quinine loading dose in cerebral malaria. Am. J. Trop. Med. Hyg. 32 (1983) 1-5
46. Sharma A.M., Keller F., Boeckh M., Heitz J., and Borner K. Quinine dosage in severe malaria with renal failure necessitating haemodialysis. Eur. J. Clin. Pharmacol. 36 (1989) 535-536
47. Franke U., Proksch B., Müller M., Risler T., and Ehninger G. Drug monitoring of quinine by HPLC in cerebral malaria with acute renal failure treated by haemofiltration. Eur. J. Clin. Pharmacol. 33 (1987) 293-296
48. Artemether-quinine Meta-analysis Group. A meta-analysis using individual patient data of trials comparing artemether with quinine in the treatement of severe falciparum malaria. Trans R Soc Med Hyg 95 (2001) 637-650
49. South East Asian Quinine Artesunate Malaria Trial group. Artesunate versus quinine for treatment of severe falciparum malaria:a randomised trial. Lancet 366 (2005) 717-725
50. Basco L.K., and Lebras J. Activity in vitro of doxycycline against multidrug-resistant Plasmodium falciparum. Trans. R. Soc. Trop. Med. Hyg. 87 (1993) 469-470
51. Losert H., Schmid K., Wifing S., Winkler S., Staudinger T., Kletzmayr J., et al. Experience with severe Plasmodium falciparum malaria in the intensive care unit. Intensive Care Med. 26 (2000) 195-201
52. English M., Ahmed M., Ngando C., Berkley J., and Ross A. Blood transfusion for severe anaemia in children in a Kenian hospital. Lancet 359 (2002) 494-495
53. Phu N.H., Hien T.T., Hoang Mai N.T., Chau T.T., Chuong L.V., Loc P.P., et al. hemofiltration and peritoneal dialysis in infection-associated acute renal failure in Vietnam. N. Engl. J. Med. 347 (2002) 895-902
54. Matteelli A., Colombini P., Gulletta F., Castelli F., and Carosi G. Epidemiological features and case management practices of imported malaria in northern Italy 1991-1995. Trop. Med. Intern. Health 4 (1999) 653-657
55. Helbok R., Dent W., Nacher M., Lackner P., Treeprasertsuk S., Krudsood S., et al. The use of the multi-organ-dysfunction score to discriminate different levels of severity in severe and complicated Plasmodium falciparum malaria. Am. J. Trop. Med. Hyg. 72 (2005) 150-154
56. Badiaga S., Brouqui P., Carpentier J.P., Hovette P., Duigou F., Manelli J.C., et al. severe imported malaria: clinical presentation at the time of hospital admission and outcome in 42 cases diagnosed from 1996 to 2002. J. Emerg. Med. 29 (2005) 375-382